Literature DB >> 26188382

Thyroid Hürthle cell tumors: research of potential markers of malignancy.

G Donatini1, A Beaulieu2, M Castagnet2, J-L Kraimps2, P Levillain3, G Fromont3.   

Abstract

INTRODUCTION: Hurthle cell tumors (HCTs) are rare thyroid neoplasia. To date, capsular and/or vascular invasion are the only findings predicting malignancy. Recently, mutation of 19p13, encoding two proteins involved in cell proliferation and apoptosis (GRIM-19 and p19), has been described. The aim of our study is to evaluate the cellular proliferation index (Ki67), GRIM-19 and p19 expression as diagnostic markers of malignancy in HCT.
MATERIALS AND METHODS: Eighty patients with HCT (32 carcinomas, 48 adenomas) whom underwent surgery in our center were included. Samples of both neoplastic lesions and adjacent normal thyroid tissue were analyzed by means of tissue micro-arrays. Correlations between expressions of Ki67, GRIM-19 and p19 and final histology were analyzed.
RESULTS: Mean size of the lesion was higher in carcinomas than in adenomas (p = 0.01). GRIM-19 and p19 were significantly underexpressed in Hurthle cells tumors compared to normal tissue (p = 0.0004 and p = 0.0001, respectively). Ki67 and GRIM-19 were, respectively, higher and down-expressed in carcinomas compared to adenomas (p = 0.0004 and p = 0.005, respectively). On multivariate analysis, size correlates with carcinoma diagnosis. Neither GRIM-19 nor Ki67 index was related to size. The expression of p19 was reduced in both adenoma and carcinoma but differences were not statistically significant (p = 0.13).
CONCLUSIONS: Our study suggest that Ki67 and GRIM-19 correlate with malignancy in HCT. The expression of p19 is down-regulated in HCT, but it is not diagnostic of carcinoma. Ki67 and GRIM-19 may potentially help as cytological markers of malignancy in HCT.

Entities:  

Keywords:  Hürthle cell tumors; Immune-histochemical markers; Thyroid malignancy markers

Mesh:

Substances:

Year:  2015        PMID: 26188382     DOI: 10.1007/s40618-015-0356-x

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  33 in total

Review 1.  Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance.

Authors:  V Máximo; M Sobrinho-Simões
Journal:  Virchows Arch       Date:  2000-08       Impact factor: 4.064

Review 2.  Solitary, multiple, and familial oxyphil tumours of the thyroid gland.

Authors:  R Katoh; H R Harach; E D Williams
Journal:  J Pathol       Date:  1998-11       Impact factor: 7.996

3.  Hurthle cell carcinoma: a population-level analysis of 3311 patients.

Authors:  Paolo Goffredo; Sanziana A Roman; Julie A Sosa
Journal:  Cancer       Date:  2012-08-14       Impact factor: 6.860

Review 4.  Familial thyroid cancer.

Authors:  O Alsanea; O H Clark
Journal:  Curr Opin Oncol       Date:  2001-01       Impact factor: 3.645

Review 5.  Hurthle cell tumours of the thyroid. Personal experience and review of the literature.

Authors:  A Barnabei; E Ferretti; R Baldelli; A Procaccini; G Spriano; M Appetecchia
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-12       Impact factor: 2.124

6.  Survival and prognosis in Hürthle cell carcinoma of the thyroid gland.

Authors:  Neil Bhattacharyya
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-02

7.  The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3.

Authors:  Jun Zhang; Jinbo Yang; Sanjit K Roy; Silvia Tininini; Jiadi Hu; Jacqueline F Bromberg; Valeria Poli; George R Stark; Dhananjaya V Kalvakolanu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-16       Impact factor: 11.205

8.  Hürthle cell carcinoma of the thyroid: Retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003.

Authors:  S C Mills; M Haq; W J B Smellie; C Harmer
Journal:  Eur J Surg Oncol       Date:  2008-08-21       Impact factor: 4.424

9.  CDK5-mediated phosphorylation of p19INK4d avoids DNA damage-induced neurodegeneration in mouse hippocampus and prevents loss of cognitive functions.

Authors:  María Florencia Ogara; Laura M Belluscio; Verónica de la Fuente; Bruno G Berardino; Silvina V Sonzogni; Laura Byk; Mariela Marazita; Eduardo T Cánepa
Journal:  Biochim Biophys Acta       Date:  2014-04-03

10.  Point mutation in GRIM-19: a new genetic lesion in Hurthle cell thyroid carcinomas.

Authors:  A Fusco; G Viglietto; M Santoro
Journal:  Br J Cancer       Date:  2005-05-23       Impact factor: 7.640

View more
  5 in total

1.  Hürthle Cell Carcinoma in a Lingual Thyroid.

Authors:  Jagdeep S Thakur; Naina Verma; Riya Singh
Journal:  Med Princ Pract       Date:  2018-06-13       Impact factor: 1.927

2.  [Pathogenic role of NDUFA13 inactivation in spontaneous hepatitis in mice and the mechanism].

Authors:  Xiaohui Xu; Rui Li; Xin Zeng; Xin Wang; Bingqian Xue; Daochao Huang; Yi Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-01-30

3.  Issues in Managing Hurthle Cell Carcinoma of Thyroid: A Case Report.

Authors:  Patricia Tai; Martin Korzeniowski; Evgeny Sadikov; Kurian Joseph; Angus Kirby; Jon Tonita; Aamer Mahmud
Journal:  Cureus       Date:  2017-04-14

Review 4.  The Molecular Landscape of Hürthle Cell Thyroid Cancer Is Associated with Altered Mitochondrial Function-A Comprehensive Review.

Authors:  Sonam Kumari; Ruth Adewale; Joanna Klubo-Gwiezdzinska
Journal:  Cells       Date:  2020-06-27       Impact factor: 6.600

5.  Hürthle cell-predominant thyroid fine needle aspiration cytology: A four risk-factor model highly accurate in excluding malignancy and predicting neoplasm.

Authors:  Lisi Yuan; Christian Nasr; James F Bena; Tarik M Elsheikh
Journal:  Diagn Cytopathol       Date:  2022-06-08       Impact factor: 1.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.